methamphetamine has been researched along with sch 23390 in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (12.00) | 29.6817 |
| 2010's | 38 (76.00) | 24.3611 |
| 2020's | 6 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukakusa, A; Hayase, M; Ito, M; Kim, HC; Kumagai, N; Mizoguchi, H; Nabeshima, T; Nagai, T; Otsuka, N; Sato, K; Takuma, K; Yamada, K | 1 |
| Baucum, AJ; Cook, GA; Fleckenstein, AE; Gibb, JW; Hadlock, GC; Hanson, GR; Horner, KA; King, JL; Wilkins, DG | 1 |
| McGregor, IS; van Nieuwenhuijzen, PS | 1 |
| Beauvais, G; Becker, K; Cadet, JL; Gilmore, K; Jayanthi, S; Ladenheim, B; McCoy, MT; Wood, W | 1 |
| Gulley, JM; Hall, DA; Powers, JP | 1 |
| Brennan, KA; Carati, C; Fitzmaurice, PS; Lea, RA; Schenk, S | 1 |
| Hiranita, T; Nawata, Y; Yamamoto, T | 1 |
| Jang, CG; Kim, HC; Lee, HK; Lee, SY; Yoo, JH | 1 |
| Beauvais, G; Cadet, JL; Jayanthi, S; Ladenheim, B; McCoy, MT | 1 |
| Hishida, S; Kasuda, S; Kinoshita, H; Matsui, K; Minami, T; Nishiguchi, M; Nishio, H; Ouchi, H; Takahashi, M; Yamamura, T | 1 |
| Kurokawa, K; Ohkuma, S; Shibasaki, M | 1 |
| Chirwa, S; Khoshbouei, H; Stanwood, G; Swant, J | 1 |
| Kurokawa, K; Mizuno, K; Ohkuma, S; Shibasaki, M | 1 |
| Angulo, JA; Ghazaryan, N; Mexhitaj, I; Ordonez, D; Tulloch, I | 1 |
| Kiyokage, E; Kurokawa, K; Mizuno, K; Ohkuma, S; Shibasaki, M; Toida, K | 1 |
| Atwell, K; Beauvais, G; Cadet, JL; Jayanthi, S; Ladenheim, B | 1 |
| Bhatt, P; Lodi, S; Raffa, RB; Ramoz, L; Rawls, SM; Reitz, AB; Tallarida, C; Tallarida, RJ | 1 |
| Chiu, YT; Lisek, R; Liu-Chen, LY; Rawls, SM; Reitz, AB; Xu, W; Yuvasheva, E | 1 |
| Chen, YW; Kao, HY; Lai, WS; Min, MY | 1 |
| Menaker, M; Mohawk, JA; Pezuk, P | 1 |
| Friend, DM; Keefe, KA | 1 |
| Kaizaki, A; Numazawa, S; Tanaka, S | 1 |
| Chirwa, S; Lee, KN; Oliver, E; Pellom, ST | 1 |
| Alburges, ME; Cordova, NM; Hanson, GR; Hoonakker, AJ; Martin, AL; McFadden, LM; Robson, CM | 1 |
| Gonzalez, AE; McDougall, SA; Mohd-Yusof, A; Veliz, A | 1 |
| Agata, K; Ashihara, E; Daido, K; Kitamura, Y; Nishimura, K; Oka, T; Takata, K; Tashiro, N; Todo, M; Toshikawa, A; Tsushima, J; Yoshimoto, K | 1 |
| Akins, CK; Levi Bolin, B; Singleton, DL | 1 |
| Ge, Zj; Jin, Y; Li, J; Liu, X; Wang, H; Yang, L; Zhang, S; Zheng, J | 1 |
| Harper, DN; Harrow, CC; Macaskill, AC | 1 |
| Goda, Y; Hall, FS; Ito, M; Kikura-Hanajiri, R; Lesch, KP; Moriya, Y; Murphy, DL; Ohara, A; Piao, YS; Sora, I; Uhl, GR | 1 |
| Bisagno, V; Cadet, JL; García-Rill, E; González, B; Muñiz, JA; Rivero-Echeto, C; Urbano, FJ | 1 |
| Rauhut, AS | 1 |
| Gonzalez, AE; McDougall, SA; Mohd-Yusof, A; Rudberg, KN; Stone, MJ; Veliz, A | 1 |
| Cai, WT; Kim, JH; Lee, YH; Lee, YS; Park, KT; Yoon, HS | 1 |
| Aarde, SM; Cole, M; Grant, Y; Nguyen, JD; Taffe, MA; Vandewater, SA | 1 |
| Hong, SI; Hwang, JY; Jang, CG; Kim, HC; Lee, SY; Ma, SX; Oh, JH; Seo, JY | 1 |
| Cho, J; Delis, F; Kim, R; Rocco, MJ; Thanos, PK; Volkow, ND | 1 |
| Groman, SM; Lee, D; Rich, KM; Smith, NJ; Taylor, JR | 1 |
| Chen, Z; Dolan, SB; Gatch, MB; Huang, R | 1 |
| Cho, EH; Jang, CG; Jeong, JH; Kim, HC; Kim, NH; Mai, HN; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ | 1 |
| Bernardi, A; Bisagno, V; Cadet, JL; García-Rill, E; Gomez, N; González, B; Jayanthi, S; Sosa, MH; Torres, OV; Urbano, FJ | 1 |
| Cho, MC; Dang, DK; Jang, CG; Jeong, JH; Kim, HC; Lee, YS; Nah, SY; Nguyen, PT; Shin, EJ; Tran, HQ | 1 |
| Milewski, A; Rawls, SM; Reitz, AB; Saber, I; Walker, EA | 1 |
| Jablonski, SA; Vorhees, CV; Williams, MT | 1 |
| Cha, HJ; Gu, SM; Hong, JT; Seo, SW; Yun, J | 1 |
| Avchalumov, Y; Mandyam, C; Piña-Crespo, J; Trenet, W | 1 |
| Anooshe, M; Haghparast, A; Karimi-Haghighi, S; Mousavi, Z; Nouri, K | 1 |
| Gao, B; Li, T; Liang, M; Liu, X; Qian, H; Shang, Q; Wang, J; Xi, Z; Xiao, J | 1 |
| Ahadi, R; Asgari, HR; Haghparast, A; Karimi-Haghighi, S; Shabani, R; Sharifi, A | 1 |
| Abdoli, N; Farnia, V; Ghazvini, H; Hosseini, M; Khazaie, H; Khodamoradi, M; Shahveisi, K | 1 |
50 other study(ies) available for methamphetamine and sch 23390
| Article | Year |
|---|---|
Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesics, Opioid; Animals; Benzazepines; Brain Chemistry; Cyclic AMP-Dependent Protein Kinases; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Inbred ICR; Morphine; Nucleus Accumbens; Oxidopamine; Protein Kinase Inhibitors; Raclopride; Receptors, Dopamine D1; Signal Transduction; Sympatholytics; Synapses; Tissue Plasminogen Activator; Tyrosine 3-Monooxygenase | 2007 |
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
Topics: Animals; Benzazepines; Blotting, Western; Data Interpretation, Statistical; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; In Vitro Techniques; Male; Methamphetamine; Neostriatum; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Sympathectomy, Chemical; Synaptosomes | 2009 |
Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
Topics: Animals; Baclofen; Benzazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Flumazenil; Hypothermia; Illicit Drugs; Male; Methamphetamine; Morpholines; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Rats; Rats, Wistar; Ritanserin; Sodium Oxybate; Telemetry | 2009 |
Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum.
Topics: Animals; Apoptosis; Benzazepines; Corpus Striatum; Dopamine Agents; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Male; Methamphetamine; Models, Biological; Neurons; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Synaptic Transmission | 2009 |
Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
Topics: Amphetamine; Analysis of Variance; Animals; Benzazepines; Catheters, Indwelling; Dopamine; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Motor Activity; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Serotonin; Serotonin Antagonists; Spiro Compounds; Sulfonamides | 2009 |
Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.
Topics: Animals; Antipsychotic Agents; Benzazepines; Central Nervous System; Cocaine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Self Administration | 2009 |
A tryptamine-derived catecholaminergic enhancer, (-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP], attenuates reinstatement of methamphetamine-seeking behavior in rats.
Topics: Adrenergic Agents; Amisulpride; Amphetamine-Related Disorders; Animals; Benzazepines; Benzofurans; Central Nervous System Stimulants; Conditioning, Classical; Cues; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Methamphetamine; Rats; Rats, Wistar; Self Administration; Sulpiride | 2010 |
GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice.
Topics: Amphetamine-Related Disorders; Analysis of Variance; Animals; Apomorphine; Autoradiography; Behavior, Animal; Benzazepines; Brain Mapping; Dopamine Agonists; Drug Interactions; Flunitrazepam; GABA Modulators; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Protein Binding; Raclopride; Receptors, GABA-A; Serotonin Antagonists; Tritium; Tropanes | 2010 |
Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; Cyclic AMP Response Element Modulator; Cytoskeletal Proteins; Dopamine Antagonists; Early Growth Response Transcription Factors; Fos-Related Antigen-2; Genes, Immediate-Early; JNK Mitogen-Activated Protein Kinases; Male; Methamphetamine; Nerve Tissue Proteins; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; RNA, Messenger | 2010 |
Effects of dopamine antagonists on methamphetamine-induced dopamine release in high and low alcohol preference rats.
Topics: Alcoholism; Animals; Animals, Inbred Strains; Benzazepines; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Ethanol; Haloperidol; Methamphetamine; Rats; Rats, Wistar; Receptors, Dopamine; Serotonin | 2010 |
Methamphetamine-induced up-regulation of α2/δ subunit of voltage-gated calcium channels is regulated by DA receptors.
Topics: Amines; Analysis of Variance; Animals; Benzazepines; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Central Nervous System Stimulants; Cerebral Cortex; Conditioning, Operant; Cyclohexanecarboxylic Acids; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Gabapentin; gamma-Aminobutyric Acid; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neurons; Protein Subunits; Receptors, Dopamine; Sulpiride; Up-Regulation | 2010 |
Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus.
Topics: Animals; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Methamphetamine; Mice; Mice, Inbred C57BL; Piperazines; Serotonin Antagonists; Synaptic Transmission | 2010 |
Regulation of ryanodine receptors by dopamine D1 receptors during methamphetamine-induced place conditioning.
Topics: Animals; Benzazepines; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Central Nervous System Stimulants; Conditioning, Psychological; Dantrolene; Dopamine Antagonists; Dose-Response Relationship, Drug; Gene Expression Regulation; Injections, Intraventricular; Male; Methamphetamine; Mice; Muscle Relaxants, Central; Nifedipine; Receptors, Dopamine D1; Ryanodine Receptor Calcium Release Channel; Sulpiride | 2010 |
Role of neurokinin-1 and dopamine receptors on the striatal methamphetamine-induced proliferation of new cells in mice.
Topics: Analysis of Variance; Androstanes; Animals; Benzazepines; Benzimidazoles; Bromodeoxyuridine; Cell Proliferation; Central Nervous System Stimulants; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Drug Administration Routes; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurogenesis; Neurokinin-1 Receptor Antagonists; Raclopride; Receptors, Dopamine; Receptors, Neurokinin-1 | 2011 |
Dopamine D1 receptor signaling system regulates ryanodine receptor expression after intermittent exposure to methamphetamine in primary cultures of midbrain and cerebral cortical neurons.
Topics: Animals; Benzazepines; Carbazoles; Cells, Cultured; Central Nervous System Stimulants; Cerebral Cortex; Dactinomycin; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Female; Gene Expression Regulation; Mesencephalon; Methamphetamine; Mice; Neurons; Pregnancy; Protein Synthesis Inhibitors; Pyrroles; Quinpirole; Receptors, Dopamine D1; Ryanodine Receptor Calcium Release Channel; Signal Transduction | 2011 |
Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways.
Topics: Animals; Benzazepines; Biomarkers; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Fever; Heat-Shock Proteins; HSP40 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Male; Methamphetamine; Mitochondria; Neostriatum; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Stress, Physiological; Time Factors; Up-Regulation | 2011 |
Mephedrone ("bath salt") pharmacology: insights from invertebrates.
Topics: Animals; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Data Interpretation, Statistical; Dopamine Antagonists; Environment; Illicit Drugs; Invertebrates; Methamphetamine; Planarians; Stereotyped Behavior; Substance Withdrawal Syndrome | 2012 |
Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Male; Methamphetamine; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2012 |
A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Disease Models, Animal; Estradiol; Estrogens; Female; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Neurons; Proto-Oncogene Proteins c-akt; Psychoses, Substance-Induced; Raclopride; Schizophrenia; Sex Factors | 2014 |
Methamphetamine and dopamine receptor D1 regulate entrainment of murine circadian oscillators.
Topics: Animals; Benzazepines; Biological Clocks; Circadian Rhythm; Gene Expression; Male; Methamphetamine; Mice; Mice, Knockout; Motor Activity; Period Circadian Proteins; Receptors, Dopamine D1 | 2013 |
A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Fever; Hot Temperature; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2013 |
New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Corpus Striatum; Designer Drugs; Dopamine; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Male; Methamphetamine; Mice; Motor Activity; Pentanones; Pyrrolidines; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2014 |
Characterization of the guinea pig animal model and subsequent comparison of the behavioral effects of selective dopaminergic drugs and methamphetamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Circadian Rhythm; Dopamine Agents; Guinea Pigs; Locomotion; Methamphetamine | 2014 |
Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
Topics: Animals; Basal Ganglia; Benzazepines; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Methamphetamine; Neurotensin; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Self Administration | 2014 |
Role of the D1 receptor for the dopamine agonist-induced one-trial behavioral sensitization of preweanling rats.
Topics: Aging; Animals; Apomorphine; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Cocaine; Dopamine Agonists; Female; Learning; Male; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2014 |
Pharmacological assessment of methamphetamine-induced behavioral hyperactivity mediated by dopaminergic transmission in planarian Dugesia japonica.
Topics: Animals; Benzazepines; Central Nervous System; Dopamine; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Locomotion; Methamphetamine; Nerve Regeneration; Planarians; Receptors, Dopamine D1; Sequence Alignment; Sulpiride; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2014 |
Pavlovian discriminative stimulus effects of methamphetamine in male Japanese quail (Coturnix japonica).
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Cocaine; Conditioning, Classical; Coturnix; Discrimination, Psychological; Female; Generalization, Psychological; Haloperidol; Male; Methamphetamine; Nicotine; Receptors, Dopamine D1; Sexual Behavior, Animal | 2014 |
Methamphetamine modulates glutamatergic synaptic transmission in rat primary cultured hippocampal neurons.
Topics: Animals; Benzazepines; Calcium Channels, N-Type; Cells, Cultured; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Immunohistochemistry; Methamphetamine; Miniature Postsynaptic Potentials; Neurons; Patch-Clamp Techniques; Presynaptic Terminals; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2014 |
The disruptive effects of methamphetamine on delayed-matching-to-sample performance reflect proactive interference and are reduced by SCH23390.
Topics: Amphetamine-Related Disorders; Animals; Benzazepines; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Antagonists; Male; Memory Disorders; Memory, Short-Term; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2015 |
Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
Topics: Animals; Benzazepines; Body Temperature; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Female; Fever; Male; Methamphetamine; Mice, Knockout; Models, Animal; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin Plasma Membrane Transport Proteins | 2015 |
Methamphetamine blunts Ca(2+) currents and excitatory synaptic transmission through D1/5 receptor-mediated mechanisms in the mouse medial prefrontal cortex.
Topics: Animals; Benzazepines; Calcium; Calcium Channels; Calcium Channels, N-Type; Calcium Channels, T-Type; Dopamine Uptake Inhibitors; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Male; Methamphetamine; Mice; Nerve Tissue Proteins; Potassium Channels; Prefrontal Cortex; Pyramidal Cells; Receptors, AMPA; Receptors, Dopamine D1; Receptors, Dopamine D5; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Synaptic Transmission | 2016 |
Timing of SCH 23390 administration influences extinction of conditioned hyperactivity in mice.
Topics: Benzazepines; Central Nervous System Stimulants; Conditioning, Psychological; Dopamine Antagonists; Extinction, Psychological; Memory Consolidation; Mental Recall; Methamphetamine; Motor Activity; Receptors, Dopamine D1; Time Factors | 2016 |
Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
Topics: Animals; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Female; Methamphetamine; Motor Activity; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2016 |
The expression of methiopropamine-induced locomotor sensitization requires dopamine D2, but not D1, receptor activation in the rat.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Dopamine Agents; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Thiophenes | 2016 |
Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.
Topics: Administration, Inhalation; Animals; Benzazepines; Benzodioxoles; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Antagonists; Dose-Response Relationship, Drug; Electronic Nicotine Delivery Systems; Locomotion; Male; Methamphetamine; Pyrrolidines; Rats; Rats, Wistar; Reward; Self Administration; Synthetic Cathinone; Telemetry | 2016 |
The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
Topics: Animals; Benzazepines; Butyrophenones; Conditioning, Psychological; Corpus Striatum; Designer Drugs; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Hylobatidae; Locomotion; Methamphetamine; Methylamines; Mice; Nucleus Accumbens; Raclopride; Receptors, Dopamine D1; Reward; Self Administration | 2018 |
Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain.
Topics: Animals; Anxiety; Benzazepines; Body Weight; Brain; Carbon Isotopes; Central Nervous System Stimulants; Cognition; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Exploratory Behavior; Male; Methamphetamine; Psychomotor Performance; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Recognition, Psychology; Signal Transduction; Spiperone | 2017 |
Chronic Exposure to Methamphetamine Disrupts Reinforcement-Based Decision Making in Rats.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Decision Making; Male; Methamphetamine; Rats; Rats, Long-Evans; Reinforcement, Psychology | 2018 |
"Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Hallucinogens; HEK293 Cells; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Serotonin; Substance-Related Disorders | 2018 |
Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation.
Topics: Animals; Antioxidants; Behavior, Animal; Benzazepines; Central Nervous System Stimulants; Dopamine Antagonists; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Infrared Rays; Male; Membrane Potential, Mitochondrial; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Receptors, Dopamine D1 | 2018 |
The effects of single-dose injections of modafinil and methamphetamine on epigenetic and functional markers in the mouse medial prefrontal cortex: potential role of dopamine receptors.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Chromatin Immunoprecipitation; Dopamine Agents; Epigenesis, Genetic; Excitatory Postsynaptic Potentials; Histone Deacetylase 1; Histones; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Modafinil; Neurons; Patch-Clamp Techniques; Prefrontal Cortex; Raclopride; Receptors, Biogenic Amine; Receptors, Dopamine | 2019 |
Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors.
Topics: Animals; Apoptosis Regulatory Proteins; Benzazepines; Cell Differentiation; Corpus Striatum; Dopamine; Dopamine D2 Receptor Antagonists; Fever; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred ICR; Microglia; Oxidative Stress; Reactive Oxygen Species; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Tyrosine 3-Monooxygenase | 2019 |
Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.
Topics: Alkaloids; Animals; Benzazepines; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Dextroamphetamine; Discrimination Learning; Dopamine Antagonists; Dose-Response Relationship, Drug; Illicit Drugs; Ketanserin; Male; Methamphetamine; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Serotonin Antagonists | 2019 |
Learning and Memory Effects of Neonatal Methamphetamine Exposure in Sprague-Dawley Rats: Test of the Role of Dopamine Receptors D1 in Mediating the Long-Term Effects.
Topics: Animals; Animals, Newborn; Benzazepines; Central Nervous System Stimulants; Dopamine Antagonists; Male; Maze Learning; Memory; Methamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Time | 2019 |
Dopamine D1 receptor antagonist reduces stimulant-induced conditioned place preferences and dopamine receptor supersensitivity.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Cocaine; Conditioning, Psychological; Dopamine Antagonists; Locomotion; Male; Methamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2020 |
SCH23390 Reduces Methamphetamine Self-Administration and Prevents Methamphetamine-Induced Striatal LTD.
Topics: Animals; Benzazepines; Corpus Striatum; Dopamine; Learning; Long-Term Potentiation; Male; Methamphetamine; Neuronal Plasticity; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Reinforcement, Psychology; Self Administration; Synapses; Synaptic Transmission | 2020 |
Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference.
Topics: Animals; Benzazepines; CA1 Region, Hippocampal; Cannabidiol; Central Nervous System Agents; Conditioning, Psychological; Dopamine Antagonists; Male; Methamphetamine; Rats, Wistar; Receptors, Dopamine D1 | 2021 |
D1R/PP2A/p-CaMKIIα signaling in the caudate putamen is involved in acute methamphetamine-induced hyperlocomotion.
Topics: Animals; Benzazepines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Central Nervous System Stimulants; Disease Models, Animal; Humans; Locomotion; Male; Methamphetamine; Mice; Piperazines; Protein Phosphatase 2; Putamen; Receptors, Dopamine D1; Signal Transduction; Substance-Related Disorders | 2021 |
Cannabidiol impairs the rewarding effects of methamphetamine: Involvement of dopaminergic receptors in the nucleus accumbens.
Topics: Animals; Benzazepines; Cannabidiol; Conditioning, Classical; Dopamine Antagonists; Male; Methamphetamine; Nucleus Accumbens; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Sulpiride; Ventral Tegmental Area | 2022 |
REM sleep deprivation before extinction or reinstatement alters methamphetamine reward memory via D1-like dopamine receptors.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine Agents; Drug-Seeking Behavior; Extinction, Psychological; Locomotion; Male; Memory; Methamphetamine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; REM Sleep Behavior Disorder; Reward; Sleep Deprivation; Sleep, REM; Sulpiride | 2022 |